These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 17912954

  • 1. Hepatocyte transplantation for glycogen storage disease type Ib.
    Lee KW, Lee JH, Shin SW, Kim SJ, Joh JW, Lee DH, Kim JW, Park HY, Lee SY, Lee HH, Park JW, Kim SY, Yoon HH, Jung DH, Choe YH, Lee SK.
    Cell Transplant; 2007; 16(6):629-37. PubMed ID: 17912954
    [Abstract] [Full Text] [Related]

  • 2. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
    Chou JY, Matern D, Mansfield BC, Chen YT.
    Curr Mol Med; 2002 Mar; 2(2):121-43. PubMed ID: 11949931
    [Abstract] [Full Text] [Related]

  • 3. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.
    Chou JY, Jun HS, Mansfield BC.
    Nat Rev Endocrinol; 2010 Dec; 6(12):676-88. PubMed ID: 20975743
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy for type I glycogen storage diseases.
    Chou JY, Mansfield BC.
    Curr Gene Ther; 2007 Apr; 7(2):79-88. PubMed ID: 17430128
    [Abstract] [Full Text] [Related]

  • 5. Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.
    Yiu WH, Pan CJ, Allamarvdasht M, Kim SY, Chou JY.
    Gene Ther; 2007 Feb; 14(3):219-26. PubMed ID: 17006547
    [Abstract] [Full Text] [Related]

  • 6. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
    Chou JY, Jun HS, Mansfield BC.
    J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
    [Abstract] [Full Text] [Related]

  • 7. Molecular biology and gene therapy for glycogen storage disease type Ib.
    Chou JY, Cho JH, Kim GY, Mansfield BC.
    J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
    [Abstract] [Full Text] [Related]

  • 8. Liver-directed gene therapy for murine glycogen storage disease type Ib.
    Kwon JH, Lee YM, Cho JH, Kim GY, Anduaga J, Starost MF, Mansfield BC, Chou JY.
    Hum Mol Genet; 2017 Nov 15; 26(22):4395-4405. PubMed ID: 28973635
    [Abstract] [Full Text] [Related]

  • 9. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib.
    Kim SY, Jun HS, Mead PA, Mansfield BC, Chou JY.
    Blood; 2008 Jun 15; 111(12):5704-11. PubMed ID: 18420828
    [Abstract] [Full Text] [Related]

  • 10. The molecular basis of type 1 glycogen storage diseases.
    Chou JY.
    Curr Mol Med; 2001 Mar 15; 1(1):25-44. PubMed ID: 11899241
    [Abstract] [Full Text] [Related]

  • 11. Aberrant glucose metabolism underlies impaired macrophage differentiation in glycogen storage disease type Ib.
    Jang Y, Park TS, Park BC, Lee YM, Heo TH, Jun HS.
    FASEB J; 2023 Nov 15; 37(11):e23216. PubMed ID: 37779422
    [Abstract] [Full Text] [Related]

  • 12. Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using 13C-glucose breath test.
    Turki A, Stockler S, Sirrs S, Duddy K, Ho G, Elango R.
    Mol Genet Metab Rep; 2023 Mar 15; 34():100955. PubMed ID: 36632325
    [Abstract] [Full Text] [Related]

  • 13. Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
    Zingone A, Hiraiwa H, Pan CJ, Lin B, Chen H, Ward JM, Chou JY.
    J Biol Chem; 2000 Jan 14; 275(2):828-32. PubMed ID: 10625614
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia.
    Koeberl DD, Sun B, Bird A, Chen YT, Oka K, Chan L.
    Mol Ther; 2007 Jul 14; 15(7):1253-8. PubMed ID: 17505475
    [Abstract] [Full Text] [Related]

  • 15. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
    Chen LY, Pan CJ, Shieh JJ, Chou JY.
    Hum Mol Genet; 2002 Dec 01; 11(25):3199-207. PubMed ID: 12444104
    [Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib.
    Jun HS, Weinstein DA, Lee YM, Mansfield BC, Chou JY.
    Blood; 2014 May 01; 123(18):2843-53. PubMed ID: 24565827
    [Abstract] [Full Text] [Related]

  • 17. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
    Koeberl DD, Sun BD, Damodaran TV, Brown T, Millington DS, Benjamin DK, Bird A, Schneider A, Hillman S, Jackson M, Beaty RM, Chen YT.
    Gene Ther; 2006 Sep 01; 13(17):1281-9. PubMed ID: 16672983
    [Abstract] [Full Text] [Related]

  • 18. AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.
    Koeberl DD, Pinto C, Sun B, Li S, Kozink DM, Benjamin DK, Demaster AK, Kruse MA, Vaughn V, Hillman S, Bird A, Jackson M, Brown T, Kishnani PS, Chen YT.
    Mol Ther; 2008 Apr 01; 16(4):665-72. PubMed ID: 18362924
    [Abstract] [Full Text] [Related]

  • 19. Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.
    Yiu WH, Pan CJ, Mead PA, Starost MF, Mansfield BC, Chou JY.
    J Hepatol; 2009 Nov 01; 51(5):909-17. PubMed ID: 19376605
    [Abstract] [Full Text] [Related]

  • 20. Historical highlights and unsolved problems in glycogen storage disease type 1.
    Moses SW.
    Eur J Pediatr; 2002 Oct 01; 161 Suppl 1():S2-9. PubMed ID: 12373565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.